share_log

愛帝宮：截至二零二四年二月二十九日止股份發行人的證券變動月報表

AIDIGONG: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024

香港交易所 ·  Mar 1 04:54
Summary by Moomoo AI
愛帝宮母嬰健康股份有限公司於2024年3月1日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年2月29日的股本變動情況。報告顯示，公司的普通股股本結存維持在800,000,000港元，每股面值0.01港元，總數為80,000,000,000股，本月無增減變動。優先股A類和B類的股本結存同樣無變動，均為4,000,000港元，每股面值0.01港元，總數為400,000,000股。已發行股份方面，A類和B類可換股優先股的結存數量均為187,265,918股，本月亦無增減。此外，公司於2023年3月23日根據認購協議條款向DYZH Holdings Limited配發了相同數量的A類和B類可轉換優先股。若全部可換股優先股轉換為普通股，將會發行最多374,531,836股普通股。公司秘書黃永祥確認，所有證券發行均已獲得董事會正式授權批准，並符合香港聯合交易所有限公司證券上市規則的相關要求。
愛帝宮母嬰健康股份有限公司於2024年3月1日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年2月29日的股本變動情況。報告顯示，公司的普通股股本結存維持在800,000,000港元，每股面值0.01港元，總數為80,000,000,000股，本月無增減變動。優先股A類和B類的股本結存同樣無變動，均為4,000,000港元，每股面值0.01港元，總數為400,000,000股。已發行股份方面，A類和B類可換股優先股的結存數量均為187,265,918股，本月亦無增減。此外，公司於2023年3月23日根據認購協議條款向DYZH Holdings Limited配發了相同數量的A類和B類可轉換優先股。若全部可換股優先股轉換為普通股，將會發行最多374,531,836股普通股。公司秘書黃永祥確認，所有證券發行均已獲得董事會正式授權批准，並符合香港聯合交易所有限公司證券上市規則的相關要求。
Royal Palace Maternal and Infant Health Co., Ltd. filed its latest Securities Change Month Report with Hong Kong Trading and Settlement Limited on March 1, 2024, reporting the change in share capital as of February 29, 2024. The report showed that the company's common share capital remained at HK$800,000,000 with a face value of HK$0.01 per share, totalling 80,000,000,000 shares, unchanged this month. The outstanding share capital of Class A and Class B shares was unchanged at HK$4,000,000 with a face value of HK$0.01 per share for a total of 400,000,000 shares. In terms of issued shares, the outstanding amount of Class A and Class B convertible preferred shares was 187,265,918 shares, with no increase in the current month. In addition, the Company issued an equal...Show More
Royal Palace Maternal and Infant Health Co., Ltd. filed its latest Securities Change Month Report with Hong Kong Trading and Settlement Limited on March 1, 2024, reporting the change in share capital as of February 29, 2024. The report showed that the company's common share capital remained at HK$800,000,000 with a face value of HK$0.01 per share, totalling 80,000,000,000 shares, unchanged this month. The outstanding share capital of Class A and Class B shares was unchanged at HK$4,000,000 with a face value of HK$0.01 per share for a total of 400,000,000 shares. In terms of issued shares, the outstanding amount of Class A and Class B convertible preferred shares was 187,265,918 shares, with no increase in the current month. In addition, the Company issued an equal number of Class A and Class B Convertible Preferred Shares to DYZH Holdings Limited on 23 March 2023 under the terms of the Subscription Agreement. If all convertible preferred shares are converted to ordinary shares, a maximum of 374,531,836 shares of ordinary shares will be issued. Company Secretary Wong Wing Cheung confirmed that all securities issues have been formally authorized by the Board of Directors and comply with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more